Sequential dose-intensive paclitaxel plus ifosfamide and carboplatin plus etoposide with autologous stem cell transplantation for germ cell tumor (GCT) patients (pts).

被引：0
|
作者：
Kondagunta, GV [1 ]
Bacik, J [1 ]
Bajorin, DF [1 ]
Reich, L [1 ]
Sheinfeld, J [1 ]
Bains, M [1 ]
Bosl, GJ [1 ]
Motzer, RJ [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：378S / 378S
页数：1
相关论文
共 50 条
  • [21] Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantation
    DJ Oblon
    SR Paul
    MB Oblon
    S Malik
    Bone Marrow Transplantation, 1997, 20 : 961 - 963
  • [22] Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantation
    Oblon, DJ
    Paul, SR
    Oblon, MB
    Malik, S
    BONE MARROW TRANSPLANTATION, 1997, 20 (11) : 961 - 963
  • [23] Feasibility of a combination of high dose chemotherapy ifosfamide, carboplatin, etoposide (ICE) plus stem cells and bevacizumab in refractory sarcoma and germ cell tumors.
    Jordan, K
    Kegel, T
    Mueller, LP
    Kinitz, I
    Schmoll, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 833S - 833S
  • [24] SURGICAL MANAGEMENT OF PATIENTS WITH ADVANCED GERM CELL TUMORS FOLLOWING SALVAGE CHEMOTHERAPY WITH PACLITAXEL, IFOSFAMIDE AND CISPLATIN (TIP) OR PACLITAXEL PLUS IFOSFAMIDE FOLLOWED BY HIGH DOSE CARBOPLATIN AND ETOPOSIDE WITH STEM CELL SUPPORT (TICE): MEMORIAL SLOAN KETTERING CANCER CENTER (MSKCC) EXPERIENCE
    Imnadze, Mariam
    Feldman, Darren
    Carver, Brett
    Bosl, George
    Motzer, Robert
    Bajorin, Dean
    Sheinfeld, Joel
    JOURNAL OF UROLOGY, 2015, 193 (04): : E110 - E110
  • [25] Paclitaxel, ifosfamide, and cisplatin (TIP) salvage therapy for patients (pts) with relapsed testicular germ cell tumors (GCT).
    Mardiak, J
    Salek, T
    Sycova-Mila, Z
    Hlavata, Z
    Obertova, J
    Mego, M
    Reckova, M
    Koza, I
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 414S - 414S
  • [26] Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support
    Elias, AD
    Wheeler, C
    Ayash, LJ
    Schwartz, G
    Ibrahim, J
    Mills, L
    McCauley, M
    Coleman, N
    Warren, D
    Schnipper, L
    Antman, KH
    Teicher, BA
    Frei, E
    CLINICAL CANCER RESEARCH, 1998, 4 (06) : 1443 - 1449
  • [27] DOSE-INTENSIVE CHEMOTHERAPY IN REFRACTORY GERM-CELL CANCER - A PHASE-I/II TRIAL OF HIGH-DOSE CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    NICHOLS, CR
    TRICOT, G
    WILLIAMS, SD
    VANBESIEN, K
    LOEHRER, PJ
    ROTH, BJ
    AKARD, L
    HOFFMAN, R
    GOULET, R
    WOLFF, SN
    GIANNONE, L
    GREER, J
    EINHORN, LH
    JANSEN, J
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (07) : 932 - 939
  • [28] HIGH-DOSE TREATMENT WITH CARBOPLATIN, ETOPOSIDE, AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION IN RELAPSED OR REFRACTORY GERM-CELL CANCER - A PHASE I/II STUDY
    SIEGERT, W
    BEYER, J
    STROHSCHEER, I
    BAURMANN, H
    OETTLE, H
    ZINGSEM, J
    ZIMMERMANN, R
    BOKEMEYER, C
    SCHMOLL, HJ
    HUHN, D
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) : 1223 - 1231
  • [29] Secondary leukemias in refractory germ cell tumor patients undergoing autologous stem-cell transplantation using high-dose etoposide
    Houck, W
    Abonour, R
    Vance, G
    Einhorn, LH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2155 - 2158
  • [30] Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors
    Feldman, Darren R.
    Glezerman, Ilya
    Patil, Sujata
    Van Alstine, Lindsay
    Bajorin, Dean F.
    Fischer, Patricia
    Hughes, Amanad
    Sheinfeld, Joel
    Bains, Manjit
    Reich, Lilian
    Woo, Kaitlin
    Giralt, Sergio
    Bosl, George J.
    Motzer, Robert J.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (05) : 453 - 460
12345